Qianwen Gao

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Journal: Haematologica

Published: February 24, 2026

Rho-related GTP-binding protein RhoE (RND3) regulates multiple myeloma bone disease.

Rho-related GTP-binding protein RhoE (RND3) regulates multiple myeloma bone disease.

Journal: Cancer cell international

Published: June 30, 2025

Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.

Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.

Journal: International journal of cancer

Published: April 04, 2025

LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma.

LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma.

Journal: Biochemical pharmacology

Published: January 18, 2025

The mitochondrial protease ClpP is a promising target for multiple myeloma treatment.

The mitochondrial protease ClpP is a promising target for multiple myeloma treatment.

Journal: Biochemical pharmacology

Published: November 07, 2024

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Journal: Cell death & disease

Published: April 23, 2024

Ferroptosis-related prognostic model of mantle cell lymphoma.

Ferroptosis-related prognostic model of mantle cell lymphoma.

Journal: Open medicine (Warsaw, Poland)

Published: March 05, 2024

Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide.

Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide.

Journal: British journal of haematology

Published: December 08, 2023

RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor.

RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor.

Journal: Cancer letters

Published: September 01, 2023

Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma.

Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma.

Journal: Life sciences

Published: June 23, 2023

Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.

Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.

Journal: The journal of gene medicine

Published: April 27, 2023

Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.

Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.

Journal: Cancer letters

Published: March 26, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026